SM
PHAS

Sabby Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Sabby Management’s Portfolio PHAS Stock Details PHAS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
2021
Q1 		$52K Sell
2020
Q4 		$218K Sell
2020
Q3 		$279K Buy
2020
Q2 		$354K Sell
2020
Q1 		$356K Buy
2019
Q4 		$576K Sell
2019
Q3 		$520K Buy
2019
Q2 		$1.09M Buy